Cargando…

Combining immunotherapy and radiotherapy in hepatocellular carcinoma: the importance of irradiated tumor burden and the possible role of a low dose radiotherapy induction strategy

Detalles Bibliográficos
Autores principales:	Grassberger, Clemens, King, Gentry, Apisarnthanarax, Smith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174792/ https://www.ncbi.nlm.nih.gov/pubmed/37180671 http://dx.doi.org/10.21037/tcr-23-192

Ejemplares similares

Low dose radiotherapy for COVID pneumonia: Irradiate to Eradicate – Will it be possible?
por: Deokar, Kunal, et al.
Publicado: (2021)

Apoptosis induction and tumor cell repopulation: The yin and yang of radiotherapy
por: Lauber, Kirsten, et al.
Publicado: (2011)

Low-dose irradiation for reversing immunotherapy resistance: how to translate?
por: Ochoa-de-Olza, Maria, et al.
Publicado: (2022)

Low-Dose Radiotherapy for Late-Stage COVID-19 Pneumonia?
por: Koukourakis, Michael I.
Publicado: (2020)

Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma
por: Liu, Jing, et al.
Publicado: (2017)

Stereotactic Radiotherapy for Hepatocellular Carcinoma, Radiosensitization Strategies and Radiation-Immunotherapy Combination
por: Pérez-Romasanta, Luis A., et al.
Publicado: (2021)

New developments in ablation therapy for hepatocellular carcinoma: combination with systemic therapy and radiotherapy
por: Numata, Kauzshi, et al.
Publicado: (2022)

Dose-response relationship for breast cancer induction at radiotherapy dose
por: Schneider, Uwe, et al.
Publicado: (2011)

Radiotherapy and the Tumor Stroma: The Importance of Dose and Fractionation
por: Hellevik, Turid, et al.
Publicado: (2014)

Opportunities for research in molecular radiotherapy
por: Flux, Glenn D, et al.
Publicado: (2017)

The confluence of radiotherapy and immunotherapy
por: Burnette, Byron, et al.
Publicado: (2012)

Skin-sparing mastectomy and radiotherapy: an update
por: Mokbel, Ramia, et al.
Publicado: (2006)

Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond
por: Lee, Yun Hua, et al.
Publicado: (2020)

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations
por: Colton, Madyson, et al.
Publicado: (2020)

Maximizing antimalarial efficacy and the importance of dosing strategies
por: Beeson, James G, et al.
Publicado: (2015)

Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
por: Herrera, Fernanda G., et al.
Publicado: (2022)

On the importance of modeling gold nanoparticles distribution in dose-enhanced radiotherapy
por: Rasouli, Fatemeh S, et al.
Publicado: (2019)

Pulsed reduced dose-rate radiotherapy for previously irradiated tumors in the brain and spine
por: Prabhu, Arpan V., et al.
Publicado: (2021)

The future of image-guided radiotherapy—is image everything?
por: Noble, David J, et al.
Publicado: (2018)

The Dose and Dose-Rate Effects of Paternal Irradiation on Transgenerational Instability in Mice: A Radiotherapy Connection
por: Mughal, Safeer K., et al.
Publicado: (2012)

Synergy of cancer immunotherapy and radiotherapy
por: Mansfield, Aaron S., et al.
Publicado: (2015)

Mechanisms of synergy of radiotherapy and immunotherapy
por: Pilones, Karsten A, et al.
Publicado: (2015)

Radiotherapy: the key to immunotherapy ignition?
por: Luterstein, Elaine, et al.
Publicado: (2017)

Immunotherapy as sensitizer for local radiotherapy
por: Vanneste, Ben G.L., et al.
Publicado: (2020)

The role of radiotherapy in the age of immunotherapy
por: Sato, Hiro, et al.
Publicado: (2021)

Radiotherapy and Immunotherapy in Lung Cancer
por: Hsieh, Kristin, et al.
Publicado: (2023)

Synergies Radiotherapy-Immunotherapy in Head and Neck Cancers. A New Concept for Radiotherapy Target Volumes—“Immunological Dose Painting”
por: Mireştean, Camil Ciprian, et al.
Publicado: (2020)

Concurrent immunotherapy and re‐irradiation utilizing stereotactic body radiotherapy for recurrent high‐grade gliomas
por: Mahase, Sean S., et al.
Publicado: (2023)

A preliminary investigation of re‐evaluating the irradiation dose in hepatocellular carcinoma radiotherapy applying 4D CT and deformable registration
por: Xu, Hua, et al.
Publicado: (2021)

The Paradox of COVID-19 in Sub-Saharan Africa: Why it is More Unethical Not to Investigate Low Dose Radiotherapy for COVID-19
por: Mortazavi, Seyed Alireza, et al.
Publicado: (2022)

Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy
por: De, Brian, et al.
Publicado: (2021)

A ‘Hybrid’ Radiotherapy Regimen Designed for Immunomodulation: Combining High-Dose Radiotherapy with Low-Dose Radiotherapy
por: Ji, Hongshan, et al.
Publicado: (2022)

Synergizing radiotherapy and immunotherapy: Current challenges and strategies for optimization
por: Rajeev-Kumar, Greeshma, et al.
Publicado: (2022)

Lattice or Oxygen-Guided Radiotherapy: What If They Converge? Possible Future Directions in the Era of Immunotherapy
por: Ferini, Gianluca, et al.
Publicado: (2021)

The dark side of radiotherapy-induced cell death in cancer
por: Alcalá, Sonia, et al.
Publicado: (2019)

Safely combining trabectedin with radiotherapy to treat myxoid liposarcoma
por: Chen, Mark, et al.
Publicado: (2019)

Compliance With Radiotherapy Treatment in an Apex Cancer Center of India
por: R Khanna, Nehal, et al.
Publicado: (2022)

Potential and future strategies for radiotherapy in hepatocellular carcinoma
por: Aebersold, Daniel M
Publicado: (2009)

Why aren’t we getting consistent results for heart dose and mortality during thoracic radiotherapy?
por: Xue, Jianxin, et al.
Publicado: (2020)

Dose matters for stereotactic body radiotherapy for early stage non-small cell lung cancer
por: Okoye, Christian C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_otc1dmfredm9stobrur9e3t7lt